It is argued that the social significance of nanotechnologies should be understood in terms of the politics and ethics of uncertainty. This means that the uncertainties surrounding the present and future development of nanotechnologies should not be interpreted, first and foremost, in terms of concepts of risk. It is argued that risk, as a way of managing uncertain futures, has a particular historical genealogy, and as such implies a specific politics and ethics. It is proposed, instead, that the concepts of (...) contingency and of finitude must be central to any understanding of the ethical significance of nanotechnologies, as these concepts can be used to understand the basis of recent work in science and technology studies, and the sociology of knowledge more widely, which details the multi-dimensional social nature of technological uncertainty. (shrink)

Policy makers from around the world are trying to emulate successful innovation systems in order to support economic growth. At the same time, innovation governance systems are being put in place to ensure a better integration of stakeholder views into the research and development process. In Europe, one of the most prominent and newly emerging governance frameworks is called Responsible Research and Innovation. This article aims to substantiate the following points: The concept of RRI and the concept of justice can (...) be used to derive similar ethical positions on the nano-divide. Given the ambitious policy aims of RRI, the concept may be better suited to push for ethical outcomes on access to nanotechnology and its products rather than debates based on justice issues alone. It may thus serve as a mediator concept between those who push solely for competitiveness considerations and those who push solely for justice considerations in nano-technology debates. The descriptive, non-normative Systems of Innovation approaches should be linked into RRI debates to provide more evidence on whether the approach advocated to achieve responsible and ethical governance of research and innovation can indeed deliver on competitiveness. (shrink)

There have been several conscious efforts made by different stakeholders in the area of nanoscience and nanotechnology to increase the awareness of social and ethical issues (SEI) among its practitioners. But so far, little has been done at the laboratory level to integrate a SEI component into the laboratory orientation schedule of practitioners. Since the laboratory serves as the locus of activities of the scientific community, it is important to introduce SEI there to stimulate thinking and discussion of SEI among (...) practitioners, which would eventually contribute toward the responsible development of this technology. In this article, through an example (at the Cornell NanoScale Science and Technology Facility (CNF), practitioners of which represent a section of the nano researchers’ community in the USA), it is shown how a SEI component can be incorporated into the laboratory orientation schedule of the practitioners from diverse disciplinary and institutional backgrounds. Results show that, at CNF, the practitioners enjoyed the discussion since most of them learned about SEI for the first time in their professional career. At the same time, some of them were also knowledgeable about SEI and contributed to the debates. Moreover, the SEI orientation had significant positive impact on the scientific community enabling them to self-reflect upon their own research and its implications for the wider society. This article also describes the efforts that were undertaken to disseminate this form of SEI orientation to other 13 USA universities within the National Nanotechnology Infrastructure Network (NNIN, one of the biggest networks funded from National Science Foundation for Nanotechnology research, of which CNF is a part). As a result of this effort, most of the NNIN sites have already started or were in the process of integrating a SEI component into their nanofabrication laboratories to make their users aware of SEI, ensuring eventual robust socio-technical integration in the NNIN laboratories. In the future, this form of SEI orientation can also be disseminated to other nanofabrication laboratories in the USA. (shrink)

Many developing countries have allocated significant amounts of funding for nanoscience and nanotechnology research, yet compared to developed countries, there has been little study, discussion, or debate over social and ethical issues. Using in-depth interviews, this study focuses on the perceptions of practitioners, that is, scientists and engineers, in one developing country: India. The disciplinary background, departmental affiliation, types of institutions, age, and sex of the practitioners varied but did not appear to affect their responses. The results show that 95% (...) of the Indian practitioners working in the area of nanoscience and nanotechnology research recognized ethical issues in this research area, and 60% of them could offer specific examples, which included possible ill effects on environment and human, use as a weapon, hype, professional ethics, laboratory testing on animals, cyborgs, widening the gap between rich and poor, self-replication, and longevity of human life. The results may offer opportunities for future cross-cultural research, as well as offer examples that can be used to raise the awareness of other practitioners in India and elsewhere regarding the importance of ethical issues. (shrink)

Among the many potential benefits arising from the rapidly advancing field of nanomedicine is the possibility of a whole new range of nanovaccines in which novel delivery mechanisms utilizing nanoparticles could make obsolete the use of needles for administering any vaccine. However, as the massive resources of the worldwide pharmaceutical industry are deployed to develop nanovaccines, urgent questions arise as to which diseases should be targeted and which populations will benefit most. -/- This paper explores how such targeting of nanovaccines (...) might be decided in an ethically optimal way and considers some of the practical considerations and potential problems of implementing such a global nanovaccine policy. There seems little doubt that nanomedical research could develop vaccines against most major global infectious diseases. Throughout the history of medicine, however, it is well recognized that insufficient attention and resources have been given to public health and preventive medicine and the environmental causes of ill-health remain under-researched. We urge that national governments and regional authorities of wealthier countries incentivise their powerful pharmaceutical corporations to develop nanovaccines within a global and long term perspective and not just to focus on the diseases of the developed world. (shrink)